This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/7/2024
Carla
Conference Call Coordinator
Thank you for your patience, everyone. The Mirren Pharmaceuticals report second quarter 2024 financial results and provide business update will begin shortly. During the presentation, you will have the opportunity to ask questions by pressing star followed by one on your telephone keypad. We'll be right back.
Thomas
Analyst at H.C. Wainwright (for Ed Ars)
Thank you.
Carla
Conference Call Coordinator
Good afternoon everyone and welcome to the Miron Pharmaceutics report second quarter 2024 financial results and provides business update. My name is Carla and I will be coordinating your call today. During the presentation you will have the opportunity to ask questions by pressing star followed by one on your telephone keypad and if you change your mind please press star followed by two. I will now hand you over to Andrew McKeven, Vice President of Investor Relations and Finance, to begin. Andrew, please go ahead.
You're reading a preview of the MIRM Q2 2024 earnings call.
Free account.
Disclaimer